Authors
Loading...
Randomized trial evaluates antibacterial effects of imidazole-based tetrapeptides in combating resistant Staphylococcus aureus, indicating promising leads for drug development.
Shaik et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: